Loxapine
- Generic Name
- Loxapine
- Brand Names
- Adasuve, Xylac
- Drug Type
- Small Molecule
- Chemical Formula
- C18H18ClN3O
- CAS Number
- 1977-10-2
- Unique Ingredient Identifier
- LER583670J
- Background
An antipsychotic agent used in schizophrenia. [PubChem]
- Indication
For the management of the manifestations of psychotic disorders such as schizophrenia
- Associated Conditions
- Acute Agitation, Schizophrenia
- Associated Therapies
- -
Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation
- First Posted Date
- 2017-04-12
- Last Posted Date
- 2018-06-11
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 2
- Registration Number
- NCT03110900
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain
- First Posted Date
- 2016-07-01
- Last Posted Date
- 2022-07-01
- Lead Sponsor
- University of Witten/Herdecke
- Target Recruit Count
- 4
- Registration Number
- NCT02820519
- Locations
- 🇩🇪
HELIOS Clinic Wuppertal, Wuppertal, NRW, Germany
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
Completed
- Conditions
- Interventions
- Other: Caregiver psycho-education and skills trainingOther: Caregiver support available at the study siteDrug: Paliperidone palmitateDrug: ChlorpromazineDrug: DroperidolDrug: FluphenazineDrug: HaloperidolDrug: LoxapineDrug: PerphenazineDrug: PimozideDrug: ProchlorperazineDrug: ThiothixeneDrug: ThioridazineDrug: TrifluoperazineDrug: AripiprazoleDrug: AsenapineDrug: ClozapineDrug: IloperidoneDrug: OlanzapineDrug: PaliperidoneDrug: QuetiapineDrug: RisperidoneDrug: Ziprasidone
- First Posted Date
- 2015-11-09
- Last Posted Date
- 2019-01-23
- Lead Sponsor
- Janssen Scientific Affairs, LLC
- Target Recruit Count
- 296
- Registration Number
- NCT02600741
Loxapine in the Management of Restlessness During Mechanical Ventilation Weaning
- First Posted Date
- 2010-09-02
- Last Posted Date
- 2014-07-18
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 100
- Registration Number
- NCT01193816
- Locations
- 🇫🇷
Hôpital Louis Mourier, Colombes, France
Randomized Double-blind Trial of Midazolam and Loxapine in Agitated Patients
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2006-02-10
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- University Hospital, Rouen
- Target Recruit Count
- 120
- Registration Number
- NCT00290082
- Locations
- 🇫🇷
Emergency Department, St Etienne, France
🇫🇷Emergecy department, Argenteuil, France
Loxapine and Weaning From Ventilator
Not Applicable
Completed
- Conditions
- First Posted Date
- 2005-07-22
- Last Posted Date
- 2007-07-23
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 9
- Registration Number
- NCT00122733
- Locations
- 🇫🇷
Service de Réanimation, Hopital Louis Mourier, Colombes, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath